Meet Us at SCOPE 2025
With over 4,500 attendees and 1,200 organizations from 30 countries coming together in clinical operations, innovation, and digital health, SCOPE 2025 promises to be a game-changer for the industry. The 2025 agenda has been expanded to provide deeper coverage of Patient-Centric Trial Design, Generative AI, Small Biopharma Strategies, and other key topics shaping the future […]
43rd Annual J.P Morgan Annual Healthcare Conference
The energy is incredible—packed meetings, buzzing lobbies, and excitement everywhere! Key themes taking center stage: ✨ Rare diseases and gene therapy, especially in immunology, are generating huge buzz. Optimism about the IPO window reopening is energizing conversations. Deal activity is anticipated to pick up momentum. Policy uncertainty with the new administration in Washington adds a […]
Accelerating Rare Disease Drug Development and Commercialization: Bridging Data Gaps with Integrated Patient Data & AI
How Patient Data and AI are Revolutionizing Rare Disease Drug Development and Commercialization ✨The power of patient data and AI is reshaping how pharmaceutical companies approach drug development & commercialization—enabling unprecedented precision and speed. Imagine targeting the right patient population with pinpoint accuracy, crafting messages that resonate deeply with rare disease communities, and engaging stakeholders […]
Join Clinakos Inc. and Rare Patient Voice on February 4, 2025
Join Clinakos Inc. and Rare Patient Voice on February 4, 2025, for an engaging webinar: “Accelerating Rare Disease Drug Development and Commercialization: Bridging Data Gaps with Integrated Patient Data™ & AI.” Did you know it often takes years for rare disease patients to receive an accurate diagnosis? With 1 in 10 people in the U.S. […]
Happy holidays from Clinakos
As the holiday season fills the air with warmth and joy, we take a moment to reflect on the partnerships, connections, and shared successes that have defined this past year. At Clinakos Inc., we are driven by a mission to foster innovation and collaboration across the lifesciences industry. None of our achievements would be possible […]
Wilson’s Disease Awareness Day
As December 6 approaches, we recognize Wilson’s Disease Awareness Day, a time to shed light on a rare condition that affects fewer than 1 in 30,000 people. Tarsha’s story, shared on the National Organization for Rare Disorders, is that the journey to a diagnosis was long and painful. Growing up, she endured symptoms no one […]
Day 3 at Piper Sandler Healthcare conference
As we dive into Day 3 of the Piper Sandler Healthcare Conference today, our team at Clinakos Inc. was excited with the vibrant discussions and transformative ideas shaping the future of cell therapy for oncology. One such discussion yesterday was an important discussion on “The Preview of American Society of Hematology”. Dr. Jae Park of […]
22nd Orphan Drugs & Rare Diseases Global Congress 2024 Americas
The leaders in rare diseases and orphan drug development are gathering today at the 22nd Orphan Drugs & Rare Diseases Global Congress 2024 Americas to discuss strategies and innovations to promote rare diseases product development and commercialization. One of the topics covered prominently is the scarcity of data on rare diseases and how data, including […]
Lung Cancer Awareness Month
Every year, more than 2 million people are diagnosed with lung cancer worldwide. This disease remains one of the toughest challenges in oncology, affecting millions and taking an immense toll on patients and their loved ones. As our understanding of data and AI deepens, so does our ability to fight back with precision and hope. […]
Data to Life Saving insights
When Mila Makovec was diagnosed with Batten disease, a rare and fatal neurological condition, her future seemed uncertain. But a groundbreaking, data-driven approach changed everything. Using advanced analytics and AI, researchers created a personalized genetic treatment that targeted Mila’s unique mutation, offering her a chance at life. This isn’t just a story about one patient. […]
